Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-020349

Chief Executive Officer sold 26,000 shares at $7.40 ($192,400)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2018-03-16 Sale −26,000 $7.40 $192,400 1,968,789 D: show line 1 in the form
Open-market sales · 26,000 sh · avg $7.40 · $192,400
Loading xslF345X03/doc4.xml…